Cargando…
Efficacy and safety of ondansetron for morning sickness in pregnancy: a systematic review of clinical trials
Background: Ondansetron is a selective antagonist of the serotonin 5-HT3 receptor that is commonly used to treat morning sickness. It is estimated that 70%–80% of pregnant women suffer from morning sickness, a condition characterized by nausea and vomiting. However, it is still controversial regardi...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625999/ https://www.ncbi.nlm.nih.gov/pubmed/37936910 http://dx.doi.org/10.3389/fphar.2023.1291235 |